About IBSPR

Issues in Biological Sciences and Pharmaceutical Research (IBSPR) (ISSN 2350-1588) is an international Journal monthly published online by Journal Issues. It is a double blind peer-review open access journal that publishes theoretical, empirical and experimental papers that contribute significantly to the  Biological and Pharmaceutical Science disciplines.

The journal welcomes the submission of manuscripts that meet the general scope and criteria of IBSPR publication.

Particular areas of interest include:

  • Applied Biochemistry
  • Applied Ecology
  • Biochemical Analysis
  • Biochemistry
  • Bioenergetics
  • Bioinformatics
  • Biotechnology
  • Drug Delivery
  • Ecotoxicology
  • Food/Drug Interaction
  • Genomics and Proteomics
  • Health Sector Reforms
  • Herbal Medicines Research
  • Herbal Drugs Evaluation
  • Industrial Microbiology
  • Medication Management
  • Metabolic Engineering
  • Molecular Biology and Metagenomics
  • Molecular Microbiology
  • Molecular Modeling
  • Natural Product Chemistry
  • Novel Drug Delivery System
  • Pesticides Residues Analysis
  • Pharmaceutical   Microbiology
  • Pharmaceutical Raw Material Science
  • Pharmaceutical Raw Materials Development/Utilization
  • Pharmaceutical Research
  • Pharmaceuticals
  • Pharmaceutics and Pharmaceutical Microbiology
  • Pharmacognosy
  • Pharmacokinetics and Pharmacodynamics
  • Pharmacology
  • Physical Pharmaceutics
  • Phytochemistry
  • Polymer/Cosmetic Science
  • Toxicolology

The above list is just indicative.  Journal editors, welcome thought provoking papers on areas not listed above, but, drawn within the disciplines of Biological and Pharmaceutical sciences. Decisions about papers will be communicated to authors within 3 weeks of submission. And accepted articles published within 4 weeks of acceptance.

Types of Articles:

Original Research Articles: These should describe new; confirmed; and carefully analyzed research findings, backed with experimental procedures. Articles should be presented in sufficient details for others to verify the work. The length of a full paper should be concise, and in a language that can be clearly understood. Please include in the main paper a set of key wordsand an abstract followed by INTRODUCTION, MATERIALS and METHODS, RESULTS, DISCUSSION, ACKNOWLEDGMENTS and REFERENCES. All these must be in capital letters but not underlined.

Short Research Communication: These should describe a concise, or sometimes preliminary but innovative study. A research finding that might be less substantial than a full research paper. Short research communication is limited to 3000 words (excluding references and abstract). The main sections need not conform to that of full-length papers. It should have a set of key words; an abstract- summarizing background of the work; research results and its implications. Followed by INTRODUCTION, MATERIALS and METHODS, RESULTS, DISCUSSION, ACKNOWLEDGMENTS and REFERENCES. All these must be in capital letters but not underlined.

Review or mini-review: A review article typically presents a summary and critical evaluation of information that has already been published, and considers the progress of current research toward clarifying a stated problem or topic. Submissions of reviews and perspectives covering topics of current interest are welcome and should be authoritative. Reviews should be concise, not exceeding 7 printed pages.

For more detailed information see Guide for Authors.

Peer Review Process

  1. Only articles of corresponding topics will be accepted for publishing in the collection of scientific works “Biological Sciences and  Pharmaceutical”. The Chief Editor has the right to reject articles that do not meet the theme or the Guidance for Authors requirements.
  1. The Editorial Board supports the world standards of transparent review process, practicing “double blind” review of manuscripts.
  1. Articles submitted are sent to an expert from the Editorial Board during a week. The expert, having read and understand the annotation of the article, agrees or disagrees to review the material on the grounds of its conformity or inconformity to the theme of the collection.
  1. In a two weeks’ period the reviewers review the material and assess its scientific level, filling in a “REVIEW FORM”. After that, the form is sent to the author.
  1. In the above mentioned form the viewers indicate their comments and download the files with corrections or materials that can be used while refining the article.
  1. After completing the main “REVIEW FORM”, the experts choose one of the following recommendations:
  • Accept the article – the article is ready for publication and is accepted without changes
  • Accept with corrections – the article is to be accepted if the author takes into account the corrections
  • Return for refining – the article is not accepted, it should be improved and repeatedly viewed
  • Refuse the article – the article does not meet the demands
  1. After reviewing, all the corresponding information is sent to the author. In one or two weeks, the author finalizes the article and sends the final version of it to the editors’ office. If after this period the article is not returned (or the editorial board is not informed about any delay) – the article is refused.

Appellation Procedure:

  • If the author does not agree with the reviewer’s corrections, the author has the right to send an appellation to the editors’ office in the format “reviewer’s corrections – author’s comments”. This document is to be sent to the reviewer, and the editorial staff determines conclusively.
  • If no decision is reached, the editorial staff appoints another expert.

The editorial board considers all manuscripts on the strict condition that:

  • the manuscript is your own original work, and does not duplicate any other previously published work, including your own previously published work;
  • the manuscript is not currently under consideration or peer review or accepted for publication or in press or published elsewhere; the manuscript contains nothing that is abusive, defamatory, libellous, obscene, fraudulent, or illegal;
  • for all manuscripts non-discriminatory language is mandatory. Sexist or racist terms must not be used.